Functional Roles of RNA-Binding Proteins in Plant Signaling.

Life (Basel)

Department of Biochemistry, Faculty of Medicine, Midlands State University, Main Campus, Senga Road, Gweru P Bag 9055, Zimbabwe.

Published: November 2020


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

RNA-binding proteins (RBPs) are typical proteins that bind RNA through single or multiple RNA-binding domains (RBDs). These proteins have a functional role in determining the fate or function of the bound RNAs. A few hundred RBPs were known through in silico prediction based on computational assignment informed by structural similarity and the presence of classical RBDs. However, RBPs lacking such conventional RBDs were omitted. Owing to the recent mRNA interactome capture technology based on UV-crosslinking and fixing proteins to their mRNA targets followed by affinity capture purification and identification of RBPs by tandem mass spectrometry, several hundreds of RBPs have recently been discovered. These proteome-wide studies have colossally increased the number of proteins implicated in RNA binding and unearthed hundreds of novel RBPs lacking classical RBDs, such as proteins involved in intermediary metabolism. These discoveries provide wide insights into the post-transcriptional gene regulation players and their role in plant signaling, such as environmental stress conditions. In this review, novel discoveries of RBPs are explored, particularly on the evolving knowledge of their role in stress responses. The molecular functions of these RBPs, particularly focusing on those that do not have classical RBDs, are also elucidated at the systems level.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698727PMC
http://dx.doi.org/10.3390/life10110288DOI Listing

Publication Analysis

Top Keywords

classical rbds
12
rna-binding proteins
8
plant signaling
8
rbps
8
rbds proteins
8
rbps lacking
8
proteins
7
rbds
5
functional roles
4
roles rna-binding
4

Similar Publications

Deep Riemannian Networks for end-to-end EEG decoding.

Imaging Neurosci (Camb)

March 2025

Neuromedical A.I. Lab, Department of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

State-of-the-art performance in electroencephalography (EEG) decoding tasks is currently often achieved with either Deep-Learning (DL) or Riemannian-Geometry-based decoders (RBDs). Recently, there is growing interest in Deep Riemannian Networks (DRNs) possibly combining the advantages of both previous classes of methods. However, there are still a range of topics where additional insight is needed to pave the way for a more widespread application of DRNs in EEG.

View Article and Find Full Text PDF

RNA binding proteins (RBPs) often engage multiple RNA binding domains (RBDs) to increase target specificity and affinity. However, the complexity of target recognition of multiple RBDs remains largely unexplored. Here we use Upstream of N-Ras (Unr), a multidomain RBP, to demonstrate how multiple RBDs orchestrate target specificity.

View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 crisis, driven by the SARS-CoV-2 virus and its mutant variants, poses a serious public health challenge that existing therapies struggle to address due to their ineffectiveness against new variants.
  • Researchers explored the use of nanobodies, which are small antibody mimics with high specificity, to target the receptor binding domains of these viral variants, employing advanced computational techniques to enhance their efficacy.
  • They developed a novel biparatopic nanobody-peptide conjugate, improved its stability and effectiveness through PEGylation, and suggest that integrating this new treatment with existing therapies could be a promising approach to reduce viral entry in COVID-19 patients.
View Article and Find Full Text PDF

As global vaccination campaigns against SARS-CoV-2 proceed, there is particular interest in the longevity of immune protection, especially with regard to increasingly infectious virus variants. Neutralizing antibodies (Nabs) targeting the receptor binding domain (RBD) of SARS-CoV-2 are promising correlates of protective immunity and have been successfully used for prevention and therapy. As SARS-CoV-2 variants of concern (VOCs) are known to affect binding to the ACE2 receptor and by extension neutralizing activity, we developed a bead-based multiplex ACE2-RBD inhibition assay (RBDCoV-ACE2) as a highly scalable, time-, cost-, and material-saving alternative to infectious live-virus neutralization tests.

View Article and Find Full Text PDF

Background: SARS-CoV-2 caused one of the most devastating pandemics in the recent history of mankind. Due to various countermeasures, including lock-downs, wearing masks, and increased hygiene, the virus has been controlled in some parts of the world. More recently, the availability of vaccines, based on RNA or adenoviruses, has greatly added to our ability to keep the virus at bay; again, however, in some parts of the world only.

View Article and Find Full Text PDF